Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.verified

CNCE

Price:

$8.37

Market Cap:

$0

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Industry

Biotechnology

IPO Date

2014-02-13

Stock Exchange

NASDAQ

Ticker

CNCE

The PE Ratio as of December 2025 (TTM) for Concert Pharmaceuticals, Inc. (CNCE) is -2.64

According to Concert Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.64. This represents a change of 134.06% compared to the average of -1.13 of the last 4 quarters.

Concert Pharmaceuticals, Inc. (CNCE) Historical PE Ratio (quarterly & annually)

How has CNCE PE Ratio performed in the past?

The mean historical PE Ratio of Concert Pharmaceuticals, Inc. over the last ten years is -3.71. The current -2.64 PE Ratio has changed 7.01% with respect to the historical average. Over the past ten years (40 quarters), CNCE's PE Ratio was at its highest in in the December 2015 quarter at 153.39. The PE Ratio was at its lowest in in the March 2018 quarter at -29.79.

Quarterly (TTM)
Annual

Average

-3.71

Median

-4.87

Minimum

-26.25

Maximum

16.60

Concert Pharmaceuticals, Inc. (CNCE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Concert Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 237.61%

Maximum Annual PE Ratio = 16.60

Minimum Annual Increase = -349.35%

Minimum Annual PE Ratio = -26.25

Quarterly (TTM)
Annual
YearPE RatioChange
2021-1.31-75.12%
2020-5.2786.25%
2019-2.83-45.90%
2018-5.24-185.48%
20176.12-235.78%
2016-4.51-127.17%
201516.60-349.35%
2014-6.66-74.64%
2013-26.25237.61%
2012-7.78-44.63%

Concert Pharmaceuticals, Inc. (CNCE) Average PE Ratio

How has CNCE PE Ratio performed in the past?

The current PE Ratio of Concert Pharmaceuticals, Inc. (CNCE) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.14

5-year avg

-1.71

10-year avg

-3.71

Concert Pharmaceuticals, Inc. (CNCE) PE Ratio vs. Peers

How is CNCE’s PE Ratio compared to its peers?

Concert Pharmaceuticals, Inc.’s PE Ratio is greater than Orchard Therapeutics plc (-27.11), greater than Revance Therapeutics, Inc. (-5.24), greater than Vigil Neuroscience, Inc. (-4.16), less than Checkpoint Therapeutics, Inc. (-0.05), less than iTeos Therapeutics, Inc. (-2.18), greater than Climb Bio, Inc. (-4.39), greater than G1 Therapeutics, Inc. (-7.72), greater than Y-mAbs Therapeutics, Inc. (-17.56), greater than SomaLogic, Inc. (-3.54), greater than scPharmaceuticals Inc. (-3.32),

Build a custom stock screener for Concert Pharmaceuticals, Inc. (CNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concert Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concert Pharmaceuticals, Inc. (CNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concert Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Concert Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Concert Pharmaceuticals, Inc. (CNCE)?

What is the highest PE Ratio for Concert Pharmaceuticals, Inc. (CNCE)?

What is the 3-year average PE Ratio for Concert Pharmaceuticals, Inc. (CNCE)?

What is the 5-year average PE Ratio for Concert Pharmaceuticals, Inc. (CNCE)?

How does the current PE Ratio for Concert Pharmaceuticals, Inc. (CNCE) compare to its historical average?